CA
HSTO

Cliff Asness’s Histogen Inc. Common Stock HSTO Stock Holding History

Cliff Asness’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,650
Closed -$1.94M – 2406
2018
Q1 		$1.94M Sell
1,650
-2,021
-55% -$2.23M ﹤0.01% 1374
2017
Q4 		$3.39M Buy
3,671
+2,046
+126% +$1.89M ﹤0.01% 1165
2017
Q3 		$1.78M Buy
1,625
+1,463
+903% +$1.66M ﹤0.01% 1420
2017
Q2 		$187K Buy
+162
New +$197K ﹤0.01% 2137

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
AIM
Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return

Cliff Asness's HSTO Position: Q2 2018 in Review

Cliff Asness sold out of Histogen Inc. Common Stock (HSTO) in Q2 2018, closing a stake of 1,650 shares — an estimated $1.94M sold.

Cliff Asness first reported a position in HSTO in Q2 2017 and held it in 4 quarters. The position peaked at $3.39M in Q4 2017. 61 funds tracked by Wall St. Rank hold HSTO as of Q2 2018.

  • Cliff Asness reported no remaining Histogen Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Cliff Asness sold 1,650 Histogen Inc. Common Stock shares in Q2 2018, an estimated $1.94M.
  • Cliff Asness first reported a position in Histogen Inc. Common Stock in Q2 2017 and held it in 4 quarters.
  • Cliff Asness's Histogen Inc. Common Stock position peaked at $3.39M in Q4 2017.
  • 61 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2018.

Based on AQR Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.